Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
27.06
+0.02 (0.07%)
Feb 24, 2026, 3:00 PM CST

SHA:600993 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
11,66411,25510,4239,74212,3978,681
Market Cap Growth
5.95%7.98%6.99%-21.42%42.80%15.15%
Enterprise Value
9,2508,6168,2797,56910,6986,956
Last Close Price
27.0625.5523.3121.4926.9218.66
PE Ratio
20.3421.3123.5220.3626.6820.72
Forward PE
17.8621.8021.8021.8021.8021.80
PS Ratio
3.093.023.322.763.663.11
PB Ratio
2.632.682.692.693.742.95
P/TBV Ratio
2.802.852.882.843.993.11
P/FCF Ratio
21.3738.3129.3036.5123.3036.54
P/OCF Ratio
18.5122.6217.2628.5020.7630.68
PEG Ratio
0.991.561.561.561.561.56
EV/Sales Ratio
2.452.312.642.143.162.49
EV/EBITDA Ratio
13.7813.8519.0713.9921.6118.10
EV/EBIT Ratio
15.3614.9021.5215.3223.6019.93
EV/FCF Ratio
16.9429.3323.2828.3620.1129.28
Debt / Equity Ratio
0.020.060.070.180.060.05
Debt / EBITDA Ratio
0.150.360.591.110.350.35
Debt / FCF Ratio
0.190.800.772.390.340.56
Net Debt / Equity Ratio
-0.57-0.70-0.72-0.74-0.75-0.74
Net Debt / EBITDA Ratio
-3.97-4.70-6.40-4.93-5.04-5.70
Net Debt / FCF Ratio
-4.66-9.95-7.81-10.00-4.69-9.22
Asset Turnover
0.720.750.630.770.850.78
Inventory Turnover
6.157.256.006.276.946.14
Quick Ratio
4.474.545.034.384.433.40
Current Ratio
5.024.945.544.925.053.88
Return on Equity (ROE)
13.91%13.59%12.07%13.83%15.14%15.43%
Return on Assets (ROA)
7.19%7.22%4.85%6.70%7.09%6.10%
Return on Invested Capital (ROIC)
30.35%40.72%32.51%47.99%49.86%33.67%
Return on Capital Employed (ROCE)
13.10%13.20%9.30%11.70%13.10%11.40%
Earnings Yield
4.90%4.69%4.25%4.91%3.75%4.83%
FCF Yield
4.68%2.61%3.41%2.74%4.29%2.74%
Dividend Yield
2.29%2.43%1.72%1.63%1.30%1.61%
Payout Ratio
47.94%33.57%36.71%34.49%26.80%27.59%
Buyback Yield / Dilution
0.23%0.23%0.19%-0.22%0.43%-0.81%
Total Shareholder Return
2.52%2.66%1.90%1.40%1.73%0.79%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.